ABCA3: A drug Target and Biomarker for Xenobiotic Transport (G21)

Target Name: ABCA3

NCBI ID: G21

ABCA3

ABCA3: A drug Target and Biomarker for Xenobiotic Transport

ABCA3 (ATPase-binding subunit associated with cation transport), also known as Xenobiotic-transporting ATPase, is a protein that plays a crucial role in the transport of a wide range of xenobiotics, including drugs, across cell membranes. Xenobiotics are naturally occurring substances that can have harmful effects on the body if taken in excess or if not properly managed. The ABCA3 gene has been well-studied, and its function in xenobiotic transport has been extensively investigated. In this article, we will explore the ABCA3 gene and its potential as a drug target and biomarker.

The ABCA3 Gene

The ABCA3 gene is located on chromosome 6 and encodes a protein that belongs to the family of ATPases, known as electrotransporters. These proteins use ATP energy to transport molecules across cell membranes. The ABCA3 gene is responsible for the synthesis of the ABCA3 protein, which is then translated into the functional protein that plays a critical role in xenobiotic transport.

Function of ABCA3

ABCA3 is involved in the transport of a wide range of xenobiotics across cell membranes, including drugs such as diuretics, which are used to remove excess fluid from the body. These drugs work by inhibiting the movement of water and solutes across the membrane. In order for diuretics to work, they must be able to cross the membrane and enter the cells. ABCA3 plays a vital role in this process by transporting the drugs across the membrane and allowing them to enter the cells.

In addition to its role in drug transport, ABCA3 is also involved in the regulation of cell signaling pathways. Many drugs, including antibiotics and anti-inflammatory agents, have been shown to modulate the activity of ABCA3. This suggests that ABCA3 may be a potential drug target for these drugs.

Potential Therapeutic Applications

The potential therapeutic applications for ABCA3 are vast and varied. As a drug target, ABCA3 may be used to develop new treatments for a variety of diseases. For example,ABCA3 has been shown to be involved in the transport of many different types of drugs, including diuretics, vasodilators, and anti-inflammatory agents. Therefore, drugs that can modulate the activity of ABCA3 may be developed to treat a wide range of conditions, including hypertension, heart failure, and inflammation.

In addition to its potential as a drug target, ABCA3 may also be used as a biomarker for a variety of diseases. The ABCA3 gene has been shown to be involved in the regulation of cell signaling pathways, and its expression has been associated with a number of diseases, including heart disease, cancer, and neurodegenerative diseases. Therefore, measuring the expression of ABCA3 may be a useful diagnostic tool for these diseases.

Conclusion

In conclusion, the ABCA3 gene is a highly promising drug target and biomarker for a variety of diseases. Its function in xenobiotic transport and its involvement in cell signaling pathways make it an attractive target for new treatments. Further research is needed to fully understand the potential of ABCA3 as a drug and biomarker, and to develop new treatments based on this promising gene.

Protein Name: ATP Binding Cassette Subfamily A Member 3

Functions: Catalyzes the ATP-dependent transport of phospholipids such as phosphatidylcholine and phosphoglycerol from the cytoplasm into the lumen side of lamellar bodies, in turn participates in the lamellar bodies biogenesis and homeostasis of pulmonary surfactant (PubMed:16959783, PubMed:17574245, PubMed:28887056, PubMed:31473345, PubMed:27177387). Transports preferentially phosphatidylcholine containing short acyl chains (PubMed:27177387). In addition plays a role as an efflux transporter of miltefosine across macrophage membranes and free cholesterol (FC) through intralumenal vesicles by removing FC from the cell as a component of surfactant and protects cells from free cholesterol toxicity (PubMed:26903515, PubMed:25817392, PubMed:27177387)

The "ABCA3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABCA3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets